A Study of YM178 in Patients With Symptomatic Overactive Bladder

NCT00527033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

842

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: YM178
DRUG: Placebo

Sponsor

Astellas Pharma Inc